News for Novartis India Limited (NOVARTIND.NS)

Novartis India clarifies no involvement in Alkem Labs acquisition talks, stock price rises over 7 percent.

Nity on Tuesday ended 140 points lower to form a long negative candle pattern with a minor lower shadow on the daily chart and found support around the 50-day exponential moving average at 22,240 levels.

Shahani, 74, was Novartis’ India chief when the Swiss drugmaker was involved in a brutal 7-year patent battle over its blood cancer drug Glivec.

Ranjit Shahani, was an influential figure in Indian pharma,and former President of OPPI. With a mechanical engineering degree from IIT Kanpur and an MBA from JBIMS Bombay, Shahani held notable positions at ICI and Roche Products before joining Novartis in 1997.

Ranjit Shahani, former Vice Chairman and Managing Director of Novartis India and Chairman of JB Pharmaceuticals, has passed away.

The management of Dr Reddy's has also repeatedly expressed their interest in acquiring a domestic-focused portfolio

Stocks to watch: Check out the companies making headlines before the opening bell today, on February 19, 2024.

Drug major Novartis AG has initiated a strategic review of Novartis India Ltd amid reports of putting the India listed business on the block.

Novartis AG conducts strategic review of Novartis India Limited, separate from Novartis Healthcare Private Limited in India.

India Business News: Pharma giant Novartis AG is conducting a strategic review of Novartis India, including its shareholding in the BSE listed company. The review's outcom

Q2 results 2023 news: Apart from the Dussehra stock market holiday, widely tracked companies such as Reliance Industries and Maruti Suzuki will declare their earnings this week.

Based on the OI percentage, 59 stocks, including Canara Bank, UPL, Abbott India, Sun Pharmaceutical Industries and Polycab India saw a short build-up.

Motilal Oswal recommended sell rating on Indraprastha Gas with a target price of Rs 340 in its research report dated March 15, 2023.

Geojit recommended sell rating on JK Lakshmi Cement with a target price of Rs 710 in its research report dated December 29, 2022.

Recovering from steep correction in the previous session, benchmark indices sharply on Friday amid strength in Asian markets and US equity futures. The BSE Sensex rose over 1,200 points and was seen testing the 54,000-mark, while the NSE Nifty 50 index climbed nearly 400 points and was within striking distance of 16,200 level.

The BSE Sensex and the NSE Nifty are expected to start the week on a bearish note as the escalating situation in Ukraine continues to roil global equities.

Trends on SGX Nifty indicate a flat opening for the index in India with a 5 points gains.

The market hit fresh record high during the session, but continued to see rangebound action with volatility for fourth consecutive day and closed moderately hig...

Nifty futures tumbled 109 points or 0.69 per cent to 15,666.50 on Singaporean Exchange on weekly options expiry day.